Ruti Aga's six-year ban: two years for the glucocorticoid, four for the prescription that never existed

The date 10 September returns twice in the Athletics Integrity Unit statement — once as the start of the provisional suspension, once as day one of a six-year ban. Ruti Aga. Ethiopia. Marathon. Thirty-two years old. What stopped me at that statement was not the drug. It was the paper. The doctor who signed the prescription turned out to be a family member with no medical registration; the clinic named on the pad did not exist; and the 'old prescription pad from a former workplace' was explicitly disowned by the institution it supposedly came from. Three independent verification checks. All three failed. The ban is six years, and four of them exist because an athlete chose to invent her treatment instead of documenting it.

My habit is a Liverpool desk at night with the laptop open and a spreadsheet of AIU statements running alongside. Road running offers exactly one place where a marathoner's case becomes a public document — no tribune, no mixed zone, no split sheet. Just a paragraph, a date, and occasionally a sentence that turns the whole story over. I learned to read a scoreboard like a passport stamp; in this case the scoreboard carries no time at all.

The skeleton is simple. In March, Aga won a half marathon in China. Her in-competition sample showed methylprednisolone. She cited a knee injury and produced a prescription. The AIU checked it and found a non-existent clinic, a non-registered signatory, a relative. Statements given in the investigative interview were also treated as misleading. Result: two years for the presence violation, four for tampering. Six in total.

One correction matters here, because the wider coverage has it wrong. Methylprednisolone is not a 'prohibited steroid'. It is a glucocorticoid under class S9 of the WADA Prohibited List, not an anabolic steroid under S1 — and in the current List, S9 glucocorticoids are prohibited in-competition only, by injection, oral or rectal route. The same injection out of competition is entirely legal. Intra-articular methylprednisolone for knee synovitis is ordinary sports-medicine practice in distance running.

Which means Aga had a legitimate defence available. The argument was never going to be about the drug; it was going to be about route and timing — by which path, and how many hours before the start. With genuine medical records, the case reads differently. By fabricating the prescription she destroyed the one defence that could have worked. The four tampering years are the price of that single decision.

The sanction arithmetic is worth reading too. Two years for presence plus four for tampering is not a new sentencing doctrine; it is two separate findings stacked. The two-year figure tells us the panel accepted the presence violation but rejected the no-significant-fault mitigation. The four-year term is the Code's standard tampering sanction. There is a near-paradox inside it: forged documentation is itself circumstantial evidence of concealment intent, yet it did not aggravate the presence sanction. The two findings were filed in separate boxes and added up.

What did not disappear is the 2026 Tokyo Marathon title. The violation is anchored to that March race, and the statement says nothing about disqualification scope. Standard practice removes the competition where the sample was collected, plus prize money and ranking points from that date onward. Earlier results are not annulled automatically. Her record is now split in two: the record book keeps a Major title and three second places at World Marathon Majors; the market keeps a name sponsors will avoid.

The age curve is unforgiving. A six-year ban at 32 means a return at roughly 38 — and inside the depth of Ethiopian women's marathon running, a 38-year-old returnee is not a selection option. Where multiple athletes run under 2:16, the removal of a 2:18–2:20 performer changes nothing in national selection maths. The 'loss to the sport' framing is therefore wrong. The loss is administrative.

The real economy of this case sits in the race the statement does not name. The gap between Majors and championships is filled by Asian label races — decent appearance fee, low risk, low race count. That same tier is now the AIU's highest-yield testing ground. Money and testing are colliding in the same races, and the consequence is that enforcement in road running has shifted from detection to document verification. In East African road cases the second charge is very often tampering: the first mistake is the drug, the second is the story.

The medical picture is equally clear. The person who wrote the prescription was not a registered physician; the clinic named did not exist. An athlete with a credentialed team physician either holds a TUE or observes the route-specific washout. Neither happened. The knee is the root of this story — chronic pathology, pressure to conceal it, the cheapest available treatment, and an informal medical network around it. The forgery grew in that gap.

This is where I have to restrain my favourite habit. The smallest gap is usually where the story waits, but not every gap is a story. 'Six years is excessive for a glucocorticoid' sounds sharp, and I tested it three times. The arithmetic is standard. Two years, four years, both in the Code. The disproportionate-punishment charge does not stand here, and I will not make it.

The real anomaly lies elsewhere: the six years were not imposed for the drug but for not knowing that a legal treatment pathway existed. The media's 'steroid' label simplified the case, and that simplification flattered the athlete, because a story of moral failure travels further than a story of documentary collapse. One more thing needs separating. Language and interpretation conditions in AIU interviews are a genuine concern, particularly when four years rest on statements. That concern should be recorded. It cannot become a defence of a forged prescription — mixing the two weakens both.

Six years, four of them for a piece of paper. No time in this case, no split, no hundredth of a second. Only a date, a signature, and a clinic whose door never existed. At 2 a.m., the distance between Tampere and Gold Coast disappears; the distance between an Addis training camp and a registered physician's desk does not disappear nearly as fast. When TUE filings from road runners start rising faster than ban announcements, that is the day to say the lesson has taken root. The next statement will carry someone else's name — the question is whether its first paragraph describes treatment or forgery.